← Back to Vaccine Database

COH04S1 (MVA-SARS-2-S)-Modified vaccinia ankara (sMVA) platform + synthetic SARS-CoV-2

Viral vector (Non-replicating) vaccine · VDDBV0165

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04639466 Phase 1COVID-19
NCT04977024 Phase 2COVID-19